Allergy Therapeutics (AGY)

London
Currency in GBP
7.00
+0.10(+1.45%)
Closed
AGY Scorecard
Full Analysis
Significant return over the last week
Fair Value
Day's Range
6.007.00
52 wk Range
2.508.00
Key Statistics
Edit
Bid/Ask
6.00 / 7.00
Prev. Close
6.9
Open
6.5
Day's Range
6-7
52 wk Range
2.5-8
Volume
151.99K
Average Volume (3m)
419.76K
1-Year Change
169.23%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AGY Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year
Show more

Allergy Therapeutics Company Profile

Allergy Therapeutics plc, a commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders. The company sells injectable and sublingual allergen-specific immunotherapies; and offers treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics products. Its products include Pollinex Quattro, Oralvac, Venomil, Venom ATL Polistes Dominula, Synbiotics, and Acarovac Plus. It also develops Grass MATA MPL, a subcutaneous allergen-specific immunotherapy candidate that aims to address the cause of symptoms of allergic rhinoconjunctivitis due to grass pollen; and VLP Peanut, a short-course peanut allergy vaccine. The company operates in Germany, Austria, Netherlands, Switzerland, Italy, Spain, and internationally, as well as the United Kingdom. Allergy Therapeutics plc was founded in 1998 and is headquartered in Worthing, the United Kingdom.

Compare AGY to Peers and Sector

Metrics to compare
AGY
Peers
Sector
Relationship
P/E Ratio
−8.2x−1.7x−0.5x
PEG Ratio
−0.090.000.00
Price/Book
88.7x1.6x2.6x
Price / LTM Sales
6.0x2.0x3.0x
Upside (Analyst Target)
104.4%48.0%56.3%
Fair Value Upside
Unlock35.0%10.0%Unlock

Earnings

Latest Release
Sep 29, 2022
EPS / Forecast
-0.03 / -0.92
Revenue / Forecast
24.07M / 24.10M
EPS Revisions
Last 90 days

FAQ

What Is the Allergy Therapeutics (AGY) Stock Price Today?

The Allergy Therapeutics stock price today is 7.00

What Stock Exchange Does Allergy Therapeutics Trade On?

Allergy Therapeutics is listed and trades on the London stock exchange.

What Is the Stock Symbol for Allergy Therapeutics?

The stock symbol for Allergy Therapeutics is "AGY."

What Is the Allergy Therapeutics Market Cap?

As of today, Allergy Therapeutics market cap is 333.65M.

What is Allergy Therapeutics Earnings Per Share?

The Allergy Therapeutics EPS is -0.011.

From a Technical Analysis Perspective, Is AGY a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.